CME/CE

Continuing education certificates / evaluation form 

You will receive an email with a link to the evaluation form. The survey will close on Dec. 31, 2022—please complete prior to the closing date.

Planning committee

NameTitleOrganization
David Skolnick, MDPhysicianSaint Luke’s
Jennifer SauerAdministrative AssistantSaint Luke’s
Michael Nassif, MDPhysicianSaint Luke’s
Christina HoffmanMarketing Director Client ServicesSaint Luke’s
Taylor AndersonMarketing and Public Relations ManagerSaint Luke’s
Diane CunninghamAdvanced Practice ProviderSaint Luke’s
Janet LipkeAdvanced Practice ProviderSaint Luke’s
Sarah Heavey, APPAdvanced Practice ProviderSaint Luke’s
Angela Postma, APPAdvanced Practice ProviderSaint Luke’s
Marci Ebberts, RNClinical Education SpecialistSaint Luke’s
Chip HayesPharmacistSaint Luke’s
Fred Loper, MDINMED Review Committee ChairINMED

Accreditation statements

Physician

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Missouri State Medical Association through the joint providership of Institute for International Medicine (INMED) and Saint Luke’s Health System.

The Institute for International Medicine is accredited by the Missouri State Medical Association to provide continuing medical education for physicians. Institute for International Medicine designates this Other Activity (Live Activity and Enduring Material) for a maximum of 15.5 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAFP has reviewed Dr. Robert D. Conn Heart Conference and deemed it acceptable for up to 15.00 Live AAFP Prescribed credits. Term of Approval is from 12/01/2022 to 12/02/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing

Saint Luke’s Health System is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 

15.5 contact hours 

 

Planning Committee Disclosures

David Skolnick, MD – Abbott and Medtronic: Speaker – All relevant financial relationships have been mitigated

Taylor Anderson – No relevant financial relationships

Diane Cunningham, RN, FNP-BC – No relevant financial relationships

Marci Ebberts, APRN, FNP-C, CCRN-K – No relevant financial relationships

Charles Hayes, III, PharmD, BCCP – No relevant financial relationships

Sarah Heavey, APP – No relevant financial relationships

Christina Hoffman, BS – No relevant financial relationships

Janet Lipke, RN, ANP-BC – No relevant financial relationships

Fred Loper, MD – No relevant financial relationships

Michael Nassif, MD – Astra Zeneca, Boehringer Ingelheim: Grant/Research; Vifor, Impulse Dynamics: Consultant – All relevant financial relationships have been mitigated

Angela Postma, APRN, AGNP-C – No relevant financial relationships

Jennifer Sauer – No relevant financial relationships

 

Faculty Disclosures:

C. Noel Bairy Merz, MD – iRhythm: Stock; SHL Telemedicine: Consultant – All relevant financial relationships have been mitigated

George Bakris, MD – Bayer, Vifor, Ionis, Alnylam, AstraZeneca, Janssen, Quantum, Genomics, Novo Nordisk: Consultant/Research – All relevant financial relationships have been mitigated

Javed Butler, MD, MPH, MBA – Abbott, Adrenomed, Amgen, Array, AstraZeneca, Bayer, Boehringer, Bristol Myers Squibb, CVRx, G3 Pharma, Innolife, Impulse Dynamics, Janssen, LivaNova, Luitpold, Merck, Medtronic, Novartis, Novo Nordisk, Roche, Vifor: Consultant – All relevant financial relationships have been mitigated

Kevin Bybee, MD – No relevant financial relationships

Adnan Chhatriwalla, MD – Boston Scientific: Research Grant; Edwards Lifescience, Medtronic: Proctor; Abbott Vascular, Medtronic, Edwards LIfescience: Speaker – All relevant financial relationships have been mitigated

Zachary Cox, PharmD – Cumberland Pharmaceuticals, AstraZeneca: Research Funding – All relevant financial relationships have been mitigated

Marci Ebberts, APRN, FNP-C, CCRN-K – No relevant financial relationships

James Fang, MD, FACC, FAHA, FHFSA – Johnson & Johnson, AstraZeneca, Amgen, Boehringer-Ingelheim, Novartis, Abbott: Research/Consultant – All relevant financial relationships have been mitigated

Bernard Gersh, MB, Ch.B., D.Phil. – No relevant financial relationships

Sanjaya Gupta, MD, MBA – Boston Scientific, Respicardia: Consultant; Medtronic: Consultant/Research – All relevant financial relationships have been mitigated

Chetan Huded, MD, MSc – Abbott, Missouri ACC, SCAI: Research Funding; Boston Scientific: Consultant – All relevant financial relationships have been mitigated

Dany Jacob, MD – No relevant financial relationships

Jessica Kline, DO – No relevant financial relationships

Mikhail Kosiborod, MD, FACC, FAHA – Alnylam, AstraZeneca, Amgen, Bayer, Boehringer Ingelheim, Cytokinetics, Esperionm, Eli Lilly, Janssen Lexicon, Merck, Pharmacosmos, Pfizer, Novo Nordisk, Sanofi, Vifor: Consultant; AstraZenwca, Boehringer Ingelheim: Research Grant Support – All relevant financial relationships have been mitigated

Daniel Kramer, MD, MPH – Heartcor: Consultant (Core Lab Reviewer); US Food and Drug Administration: Consultant – All relevant financial relationships have been mitigated

Kyle Lehenbauer, MD – No relevant financial relationships

Kathryn Lindley, MD – No relevant financial relationships

Donald Lloyd-Jones, MD, ScM – NIH, CMS, AHA: Grant Funding; American Heart Association: Unpaid Fiduciary Officer – All relevant financial relationships have been mitigated

Sean McCarney, MD – No relevant financial relationships

Michael Nassif, MD – Astra Zeneca, Boehringer Ingelheim: Grant/Research; Vifor, Impulse Dynamics: Consultant – All relevant financial relationships have been mitigated

Dan Nguyen, MD – No relevant financial relationships

James O’Keefe, MD – Amgen, AstraZeneca, Boehringer Ingelheim Pharma, Janssen, Lilly: Speaker’s Bureau; Cardio Tabs: CMO/Founder/Ownership – All relevant financial relationships have been mitigated

Graham Pollock, MD – No relevant financial relationships

Andrew Sauer, MD – Abbott: Speaking/Consulting; General Prognostics, Boston Scientific, Story Health, and Bodyport: Consulting/Research – All relevant financial relationships have been mitigated

John Saxon, MD – No relevant financial relationships

Kristin Sollars, MSN, RN, CCRN – No relevant financial relationships

Brett Sperry, MD – Alnylam & BridgeBio/Eidos: Consulting; Pfizer: Speaking/Consulting – All relevant financial relationships have been mitigated

Daniel Steinhaus, MD – Boston Scientific, Medtronic: Speaker – All relevant financial relationships have been mitigated

Randall Thompson, MD – No relevant financial relationships

Rafael Torosyan, MD – No relevant financial relationships

Stefanie Vamenta, MD – No relevant financial relationships

Alan Wimmer, MD – Boston Scientific: Research/Speaker; Atricure, SentreHeart, Biosense Webster, & Medtronic: Research – All relevant financial relationships have been mitigated